Tumors induce de novo steroid biosynthesis in T cells to evade immunity
Multiple mechanisms of immune evasion exploited by cancer cells have been described. Here, the authors show that genetic inactivation or pharmacological inhibition of tumor-induced Th2-mediated de novo steroidogenesis are sufficient to restore an efficient anti-tumor immune response and restrict tum...
Saved in:
Main Authors: | Bidesh Mahata, Jhuma Pramanik, Louise van der Weyden, Krzysztof Polanski, Gozde Kar, Angela Riedel, Xi Chen, Nuno A. Fonseca, Kousik Kundu, Lia S. Campos, Edward Ryder, Graham Duddy, Izabela Walczak, Klaus Okkenhaug, David J. Adams, Jacqueline D. Shields, Sarah A. Teichmann |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/3d1388c6f86c4110af3e985cacb07322 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optical backaction-evading measurement of a mechanical oscillator
by: Itay Shomroni, et al.
Published: (2019) -
Metabolic engineering strategies for de novo biosynthesis of sterols and steroids in yeast
by: Yuehao Gu, et al.
Published: (2021) - Steroids
-
Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity
by: Marla E. Tharp, et al.
Published: (2020) -
Few and far between: how HIV may be evading antibody avidity.
by: Joshua S Klein, et al.
Published: (2010)